Researchers explain the mechanisms beyond glucocorticoid resistance in infant MLLr B-ALL leukemia
B-ALL is the most common pediatric cancer and, over the years and thanks to a very effective treatment based on glucocorticoids, its 5-year survival rates have reached 85% and beyond. However, there is a B-ALL subtype, commonly ...
Aug 5, 2024
0
0